Taurine and cardiac disease: state of the art and perspectives

Can J Physiol Pharmacol. 2020 Feb;98(2):67-73. doi: 10.1139/cjpp-2019-0313.

Abstract

Taurine is a nonessential amino acid that has received much attention. Two organs, the heart and the brain, are known to produce their own taurine, but in very limited quantities. It is for this reason that supplementation with this amino acid is necessary. Today, taurine is present in almost all energy drinks. A very vast literature reported beneficial effects of taurine in hepatic dysfunction, gastrointestinal injury, kidney diseases, diabetes, and cardiovascular diseases. Most of its effects were attributed to its modulation of Ca2+ homeostasis as well as to its antioxidant properties. In this review, we will focus on the current status of taurine modulation of the cardiovascular system and discuss future avenues for its use as a supplement therapy in a specific cardiovascular disease, namely hypertrophy, and heart failure.

Keywords: calcium; heart failure; hypertension; hypertrophie; hypertrophy; insuffisance cardiaque; sodium; taurine.

Publication types

  • Review

MeSH terms

  • Animals
  • Heart Diseases / metabolism*
  • Heart Diseases / pathology
  • Humans
  • Intracellular Space / metabolism
  • Osmosis
  • Taurine / metabolism*

Substances

  • Taurine